ArticlePloS one2025
Pioneering terahertz blood analysis: Hollow-core PCF with optimized sensitivity and low loss.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Design and Optimization of Refractive Index-based Spiral Shape Twin-core Photonic Crystal Fiber Sensor for Detection of Blood Components.Cell biochemistry and biophysics · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Blood detection is crucial for the human body. Its detection is very crucial and sensitive. In this paper, a hollow core photonic crystal fiber (PCF) biosensor operating in the terahertz frequency range is proposed. The building blocks of this proposed biosensor's hexagonal cladding structure are the same square-shaped air gaps in the cladding and core. Hemoglobin, white blood cells (WBC), red blood cells (RBC), plasma and water are among the analytes that fill the core. The sensing aspects of the design will be examined using the finite element method. The COMSOL v6.1a software simulation findings show that the sensitivity for water is 93.08 percent, for plasma it is 94.55%, for hemoglobin it is 96.21%, for WBC it is 95.16%, and for RBC it is 97.05 percent. The suggested design's detection has the lowest confinement loss at frequencies between f = 1 and 2.8 THz. In addition to these, the design exhibits, under ideal design circumstances, very low and flattened dispersion, huge beam divergence, improved effective area, substantial birefringence, and negligible effective material loss. This proposed PCF biosensor is a viable option for employment in various practical applications due to its simple shape and great detecting capacity. PCF offer significant benefits for blood component analysis due to their unique structure and light-guiding properties. By enabling precise control over light-matter interaction, PCFs can be highly sensitive to the presence and characteristics of different blood components, such as red and white blood cells, platelets, hemoglobin, and glucose. This has major implications in medical diagnostics, offering advantages in speed, sensitivity, and minimally invasive testing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.